CA Stock MarketDetailed Quotes

SZLS StageZero Life Sciences Ltd

Watchlist
  • 0.040
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
4.94MMarket Cap-245P/E (TTM)

StageZero Life Sciences Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-991.86%-62.92K
58.37%-92.94K
167.28%47.82K
101.26%7.06K
90.05%-223.24K
60.59%-3.53M
77.06%-655.15K
97.22%-71.07K
77.21%-558.28K
-104.82%-2.24M
Net income from continuing operations
-61.74%-649.46K
78.68%-386.35K
-1,722.52%-821.88K
68.67%-401.54K
-206.84%-1.81M
-52.53%-11.42M
-313.78%-9.5M
97.97%-45.1K
-129.60%-1.28M
91.91%-590.5K
Operating gains losses
43.83%-147.48K
-92.19%29.41K
80.57%-188.09K
-2,703.17%-262.55K
128.57%376.37K
19.03%-2.24M
109.22%58.44K
3.64%-967.84K
99.86%-9.37K
-123.76%-1.32M
Depreciation and amortization
-26.46%43.81K
-69.32%18.28K
-77.52%38.1K
-27.41%59.58K
-36.04%59.58K
-14.10%437.45K
-31.46%125.76K
-20.57%169.44K
54.91%82.08K
-14.50%93.14K
Asset impairment expenditure
----
----
----
----
----
--7.36M
----
----
----
----
Unrealized gains and losses of investment securities
--0
--0
75,550.00%9.08K
---3.67K
--8.18K
-97.14%31.97K
--31.96K
100.04%12
--0
--0
Remuneration paid in stock
-81.92%11.78K
-81.67%11.94K
--261.09K
139.37%65.16K
-60.63%65.16K
-38.99%238.51K
134.91%238.51K
--0
-1,510.23%-165.51K
170.57%165.51K
Other non cashItems
-60.53%69.84K
-82.23%23.58K
141.53%70.34K
126.22%176.95K
118.20%132.7K
-520.52%-1.66M
71.65%-117.37K
-209.00%-169.37K
-784.84%-674.84K
-1,457.55%-729.18K
Change In working capital
63.11%608.59K
-77.80%210.2K
-27.88%679.17K
-74.98%373.12K
605.10%946.67K
905.95%3.71M
463.44%1.14M
184.09%941.78K
2,465.65%1.49M
112.76%134.26K
-Change in receivables
-292.99%-42.56K
81.40%-7.67K
-130.49%-6.24K
-50.35%22.05K
-309.51%-41.21K
121.57%95.65K
-83.02%11.11K
268.89%20.47K
147.07%44.42K
-76.65%19.67K
-Change in inventory
--0
--0
1,725.61%60.37K
--0
-80.41%12.68K
682.05%313.18K
-54.32%142.77K
101.75%3.31K
200.61%102.4K
185.64%64.71K
-Change in prepaid assets
113.57%16.06K
86.08%30.65K
-12.13%59.9K
-11.14%-118.34K
-21.09%16.47K
205.87%26.09K
7.98%43.53K
-9.60%68.17K
25.36%-106.48K
812.59%20.87K
-Change in payables and accrued expense
17.95%686.14K
-81.35%167.58K
-52.49%450.43K
-60.81%581.73K
8,782.63%898.48K
960.22%3.4M
497.47%957.76K
229.99%948.08K
256.25%1.48M
101.18%10.12K
-Change in other working capital
54.55%-51.06K
-67.41%19.64K
216.76%114.71K
-234.38%-112.33K
218.74%60.25K
-326.82%-126.41K
-153.17%-13.47K
-157.83%-98.25K
-70.14%-33.59K
109.22%18.9K
Cash from discontinued investing activities
Operating cash flow
-991.86%-62.92K
58.37%-92.94K
167.28%47.82K
101.26%7.06K
90.05%-223.24K
60.59%-3.53M
77.06%-655.15K
97.22%-71.07K
77.21%-558.28K
-104.82%-2.24M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
Net PPE purchase and sale
----
--0
----
----
--0
--0
----
----
----
--0
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
--0
----
----
--0
--0
----
----
----
--0
Financing cash flow
Cash flow from continuing financing activities
274.50%78.11K
-70.44%72.09K
-177.34%-87.93K
-47.45%20.86K
-78.40%243.85K
-55.34%1.83M
-77.63%650.6K
215.83%113.7K
-88.68%39.69K
19.84%1.13M
Net issuance payments of debt
126.39%78.11K
-70.44%72.09K
-202.62%-116.67K
-845.62%-295.95K
354.85%243.85K
174.71%290.18K
442.17%332.47K
215.83%113.7K
150.62%39.69K
16.55%-95.68K
Net common stock issuance
--0
----
--18.52K
--279.76K
----
-50.36%1.54M
-93.37%206K
--0
--0
--1.34M
Proceeds from stock option exercised by employees
--0
----
--10.22K
--37.04K
----
--0
--0
--0
----
----
Net other financing activities
----
----
----
----
----
----
----
----
----
---112.12K
Cash from discontinued financing activities
Financing cash flow
274.50%78.11K
-70.44%72.09K
-177.34%-87.93K
-47.45%20.86K
-78.40%243.85K
-55.34%1.83M
-77.63%650.6K
215.83%113.7K
-88.68%39.69K
19.84%1.13M
Net cash flow
Beginning cash position
-84.75%5.54K
68.22%26.38K
784.94%64.21K
-94.04%36.3K
-99.09%15.68K
-73.86%1.72M
-97.91%33.25K
-100.22%-9.37K
-90.55%609.21K
-73.86%1.72M
Current changes in cash
-45.59%15.19K
-201.15%-20.85K
-194.11%-40.11K
105.38%27.91K
101.85%20.61K
65.19%-1.7M
-103.43%-4.56K
101.61%42.63K
76.42%-518.59K
-625.37%-1.12M
Effect of exchange rate changes
----
----
----
----
----
---13.01K
----
----
----
----
End cash Position
-67.73%20.72K
-84.75%5.54K
-27.55%24.09K
-29.15%64.21K
-94.04%36.3K
-99.09%15.68K
-99.09%15.68K
-97.91%33.25K
-97.86%90.63K
-90.55%609.21K
Free cash from
-991.86%-62.92K
58.37%-92.94K
167.28%47.82K
101.26%7.06K
90.05%-223.24K
61.24%-3.53M
77.10%-655.15K
97.22%-71.07K
78.47%-558.28K
-104.82%-2.24M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -991.86%-62.92K58.37%-92.94K167.28%47.82K101.26%7.06K90.05%-223.24K60.59%-3.53M77.06%-655.15K97.22%-71.07K77.21%-558.28K-104.82%-2.24M
Net income from continuing operations -61.74%-649.46K78.68%-386.35K-1,722.52%-821.88K68.67%-401.54K-206.84%-1.81M-52.53%-11.42M-313.78%-9.5M97.97%-45.1K-129.60%-1.28M91.91%-590.5K
Operating gains losses 43.83%-147.48K-92.19%29.41K80.57%-188.09K-2,703.17%-262.55K128.57%376.37K19.03%-2.24M109.22%58.44K3.64%-967.84K99.86%-9.37K-123.76%-1.32M
Depreciation and amortization -26.46%43.81K-69.32%18.28K-77.52%38.1K-27.41%59.58K-36.04%59.58K-14.10%437.45K-31.46%125.76K-20.57%169.44K54.91%82.08K-14.50%93.14K
Asset impairment expenditure ----------------------7.36M----------------
Unrealized gains and losses of investment securities --0--075,550.00%9.08K---3.67K--8.18K-97.14%31.97K--31.96K100.04%12--0--0
Remuneration paid in stock -81.92%11.78K-81.67%11.94K--261.09K139.37%65.16K-60.63%65.16K-38.99%238.51K134.91%238.51K--0-1,510.23%-165.51K170.57%165.51K
Other non cashItems -60.53%69.84K-82.23%23.58K141.53%70.34K126.22%176.95K118.20%132.7K-520.52%-1.66M71.65%-117.37K-209.00%-169.37K-784.84%-674.84K-1,457.55%-729.18K
Change In working capital 63.11%608.59K-77.80%210.2K-27.88%679.17K-74.98%373.12K605.10%946.67K905.95%3.71M463.44%1.14M184.09%941.78K2,465.65%1.49M112.76%134.26K
-Change in receivables -292.99%-42.56K81.40%-7.67K-130.49%-6.24K-50.35%22.05K-309.51%-41.21K121.57%95.65K-83.02%11.11K268.89%20.47K147.07%44.42K-76.65%19.67K
-Change in inventory --0--01,725.61%60.37K--0-80.41%12.68K682.05%313.18K-54.32%142.77K101.75%3.31K200.61%102.4K185.64%64.71K
-Change in prepaid assets 113.57%16.06K86.08%30.65K-12.13%59.9K-11.14%-118.34K-21.09%16.47K205.87%26.09K7.98%43.53K-9.60%68.17K25.36%-106.48K812.59%20.87K
-Change in payables and accrued expense 17.95%686.14K-81.35%167.58K-52.49%450.43K-60.81%581.73K8,782.63%898.48K960.22%3.4M497.47%957.76K229.99%948.08K256.25%1.48M101.18%10.12K
-Change in other working capital 54.55%-51.06K-67.41%19.64K216.76%114.71K-234.38%-112.33K218.74%60.25K-326.82%-126.41K-153.17%-13.47K-157.83%-98.25K-70.14%-33.59K109.22%18.9K
Cash from discontinued investing activities
Operating cash flow -991.86%-62.92K58.37%-92.94K167.28%47.82K101.26%7.06K90.05%-223.24K60.59%-3.53M77.06%-655.15K97.22%-71.07K77.21%-558.28K-104.82%-2.24M
Investing cash flow
Cash flow from continuing investing activities 0000
Net PPE purchase and sale ------0----------0--0--------------0
Net business purchase and sale ----------------------0----------------
Cash from discontinued investing activities
Investing cash flow ------0----------0--0--------------0
Financing cash flow
Cash flow from continuing financing activities 274.50%78.11K-70.44%72.09K-177.34%-87.93K-47.45%20.86K-78.40%243.85K-55.34%1.83M-77.63%650.6K215.83%113.7K-88.68%39.69K19.84%1.13M
Net issuance payments of debt 126.39%78.11K-70.44%72.09K-202.62%-116.67K-845.62%-295.95K354.85%243.85K174.71%290.18K442.17%332.47K215.83%113.7K150.62%39.69K16.55%-95.68K
Net common stock issuance --0------18.52K--279.76K-----50.36%1.54M-93.37%206K--0--0--1.34M
Proceeds from stock option exercised by employees --0------10.22K--37.04K------0--0--0--------
Net other financing activities ---------------------------------------112.12K
Cash from discontinued financing activities
Financing cash flow 274.50%78.11K-70.44%72.09K-177.34%-87.93K-47.45%20.86K-78.40%243.85K-55.34%1.83M-77.63%650.6K215.83%113.7K-88.68%39.69K19.84%1.13M
Net cash flow
Beginning cash position -84.75%5.54K68.22%26.38K784.94%64.21K-94.04%36.3K-99.09%15.68K-73.86%1.72M-97.91%33.25K-100.22%-9.37K-90.55%609.21K-73.86%1.72M
Current changes in cash -45.59%15.19K-201.15%-20.85K-194.11%-40.11K105.38%27.91K101.85%20.61K65.19%-1.7M-103.43%-4.56K101.61%42.63K76.42%-518.59K-625.37%-1.12M
Effect of exchange rate changes -----------------------13.01K----------------
End cash Position -67.73%20.72K-84.75%5.54K-27.55%24.09K-29.15%64.21K-94.04%36.3K-99.09%15.68K-99.09%15.68K-97.91%33.25K-97.86%90.63K-90.55%609.21K
Free cash from -991.86%-62.92K58.37%-92.94K167.28%47.82K101.26%7.06K90.05%-223.24K61.24%-3.53M77.10%-655.15K97.22%-71.07K78.47%-558.28K-104.82%-2.24M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data